March 24, 2026- ZOLL® will highlight the latest sudden cardiac death research, case experiences for heart failure readmission reduction, and two Innovation Stage presentations at the American College of Cardiology Annual Scientific Session & Expo (ACC.26), March 28-30, 2026. ZOLL will sponsor a slate of educational programs to engage and connect clinicians with emerging evidence and evolving practices in cardiac care:
The ACC Innovation Stage will host two ZOLL-sponsored presentations:
- A friendly debate about approaches to HFrEF patient management with GDMT, including the LifeVest® wearable cardioverter defibrillator (WCD) as a treatment option.
- A case study highlighting a reduction in HF readmission to single digits with the implementation of ZOLL’s Heart Failure Management System (HFMS).
ZOLL is sponsoring the ACC Women in Cardiology Mix N’ Mingle, as well as events for cardiology fellows and residents.
ZOLL will also spotlight innovations in Booth 2437, including the LifeVest WCD, ZOLL HFMS, TherOx® SuperSaturated Oxygen Therapy, and WatchPAT® sleep apnea solutions.